PROZAC
FLUOXETINE HYDROCHLORIDE
Approval overview PROZAC is listed in Drugs@FDA under application 020101 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient FLUOXETINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 20MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2009-01-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROZAC is listed in Drugs@FDA under application 020101 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient FLUOXETINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 20MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2009-01-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.